Building on a legacy of innovation that spans more than half a century, Los Angeles
Biomedical Research Institute (LA BioMed) at Harbor-UCLA Medical Center is one of
the country's leading nonprofit biomedical research institutes.
LA BioMed is committed to finding practical, inexpensive solutions to real-world health
problems. Our organization has been serving the citizens of Los Angeles for over 60
years with pioneering and innovative research that led to countless diagnostics, devices
and therapies.
It is often said that “someday they will find a way.” When it comes
to discovery science that drives medical breakthroughs, “they” are
here at LA BioMed and “someday” is today.
Our ability to impact and improve global health through local discoveries
is only proportional to the generosity of others. We thank you for support
and we ask that you continue to help us make ‘someday’ happen today.


About Us

LA BioMed is a non-profit scientific research organization dedicated to saving lives not only in the greater Los Angeles metro area but throughout the world. The organization is located on the Harbor-UCLA Medical Center Campus and affiliated with the David Geffen School of Medicine at UCLA.
Read More

Mission Moment

While no one can be certain of what tomorrow brings, most of us have dreams and plans for the future – especially for our children. That was certainly true for me with my daughter...
Read More


Make a gift through PayPal to the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center by clicking on the Donate button below...

Calcium Score Predicts Future Heart Disease Among Adults with Little or No Risk Factors LA BioMed Research studied nearly 5,600 Patients over 20 years

With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of “calcium scoring” was also accurate in predicting the chances of...

LA BioMed to Study Passive Vaccination Against a Deadly Hospital-Acquired Infection NIH Grant Funds Research into New Approach for Combating Acinetobacter Infections

As one of the most common and deadliest “Superbugs,” Acinetobacter baumannii, continues to grow in strength and prevalence, Los Angeles Biomedical Research Institute (LA BioMed) infectious disease specialist Brad Spellberg, MD, is launching a study to determine if a vaccine could...

LA BioMed Celebrates the Accomplishments of Two “Legends” May 1 Event to Honor Drs. Joel D. Kopple and Robert Hockberger

Continuing a tradition of recognizing its most outstanding physician-researchers, the Los Angeles Biomedical Research Institute (LA BioMed) will celebrate the many accomplishments of Drs. Joel D. Kopple and Robert S. Hockberger on May 1 at Legends 2014 at the Torrance Marriott...

Studies Suggest Coronary Calcium Scores Can Assess Long-Term Risk for Heart Disease

Despite being available for decades, CT-based coronary artery calcium scoring has been subject to debate among doctors on whether, and how, it should be used to inform patient care. Utilizing data from five separate studies, researchers have concluded that coronary artery calcium...

Join the mailing list

Check your email and confirm the subscription